Levocetirizine Dihydrochloride Tablet
Product Images NDC 0615-8565

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 0615-8565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levocetirizine Dihcl Tabs 8565 1)

Chemical structure of levocetirizine dihydrochloride showing the molecular arrangement with chlorine, aromatic rings, a piperazine ring, and carboxylic acid groups, including dihydrochloride salt components.*

FDA Label Image

Principal Display Panel (Levocetirizine Dihcl Tabs 8565 2)

Packaging label for Levocetirizine Dihydrochloride Tablets USP 5 mg, oral tablets, packaged by Vangard Labs in Glasgow, KY. The label shows dosage strength as 5 mg, quantity of 30 tablets, lot number 8565, and temperature storage instructions. The label specifies "For Institutional Use Only" and includes multiple small barcode labels for individual tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.